Tenderwize
Back to tender search

Open House Original Discount Contracts 2025-27 - Ribociclib

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 30, 2027 · 438 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-27 - Ribociclib

70/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

70 / 100

Complexity

20 / 100

Risk factors

Contract ends automatically at the end of the month in which the patent or market exclusivity for Ribociclib expires. T...

No estimated value or volume is provided; revenue is uncertain and depends on actual prescriptions.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Conclude discount contracts for the active ingredient Ribociclib with eligible pharmaceutical entrepreneurs.
  • Ensure pharmacy software update for new discount products by submitting documents before the 3rd of the preceding month.
Show full summary

Open House procedure by Techniker Krankenkasse (TK) to conclude discount contracts (Rabattverträge) for the active ingredient Ribociclib under §130c SGB V. The process is non-competitive: any eligible pharmaceutical entrepreneur that meets the criteria (valid marketing authorization, being a pharmaceutical entrepreneur within EU/EEA) can join at any time during the contract duration (01.11.2025 – 31.10.2027). No exclusivity is granted. The notice clarifies this is not a public procurement under EU directives; legal recourse is to social courts. No estimated value is provided. Contract termination occurs automatically upon patent expiry. Documents are available online but submission is via email or post (not electronic via the platform).

Risks

Contract ends automatically at the end of the month in which the patent or market exclusivity for Ribociclib expires. T...

No estimated value or volume is provided; revenue is uncertain and depends on actual prescriptions.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Be a pharmaceutical entrepreneur within the meaning of §4(18) AMG, with a valid marketing authorization (or equivalent right) for Ribociclib.

Eligibility

  • No exclusion grounds analogous to §§123, 124 GWB for the last 3-5 years.

Administrative

  • Submit signed contract documents (including self-declaration on authorization and company – Anlage 4) via email with qualified electronic signature or by post.

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Original Discount Contracts 2025-27 - Ribociclib

Conclusion of discount contracts for the active ingredient Ribociclib with eligible pharmaceutical entrepreneurs. The contract has a maximum duration of 24 months starting 01.11.2025, ending no later than 31.10.2027. Early termination upon patent expiry.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Oct 2025 - Oct 2027

Category

Pharmaceutical products

Procurement Details

Publication date
17 Sep 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
612458-2025

Documents (1)

Similar tenders